Share class: Haleon plc

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A19,117,826,4327,447,394,721 ( 81.68 %) 0 81.68 %

Major shareholders: Haleon plc

NameEquities%Valuation
Pfizer Inc.
32.39 %
2,955,063,626 32.39 % 14 836 M p
GSK Plc
4.223 %
385,320,110 4.223 % 1 934 M p
Dodge & Cox
2.610 %
238,183,924 2.610 % 1 196 M p
The Vanguard Group, Inc.
2.570 %
234,472,500 2.570 % 1 177 M p
BlackRock Fund Advisors
1.665 %
151,907,000 1.665 % 763 M p
BlackRock Investment Management (UK) Ltd.
1.636 %
149,253,884 1.636 % 749 M p
Norges Bank Investment Management
1.563 %
142,598,000 1.563 % 716 M p
Harding Loevner LP
1.454 %
132,707,000 1.454 % 666 M p
MFS International (UK) Ltd.
1.453 %
132,536,369 1.453 % 665 M p
First Eagle Investment Management LLC
1.412 %
128,802,793 1.412 % 647 M p
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
NameEquities%Valuation
Dodge & Cox
3.949 %
180,170,635 3.949 % 1 834 M p
Fidelity Management & Research Co. LLC
2.173 %
99,150,152 2.173 % 1 009 M p
ClearBridge Investments LLC
0.9152 %
41,753,987 0.9152 % 425 M p
Harding Loevner LP
0.5615 %
25,614,627 0.5615 % 261 M p
Fisher Asset Management LLC
0.3062 %
13,967,315 0.3062 % 142 M p
RBC Private Counsel (USA), Inc.
0.2028 %
9,249,978 0.2028 % 94 M p
Aristotle Capital Management LLC
0.1984 %
9,050,366 0.1984 % 92 M p
Sculptor Capital LP
0.1948 %
8,887,098 0.1948 % 90 M p
Douglas Lane & Associates LLC
0.1871 %
8,533,768 0.1871 % 87 M p
Wells Fargo Bank NA
0.1766 %
8,055,620 0.1766 % 82 M p
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional44.55%
Pfizer Inc.32.39%
GSK Plc4.22%
Other0.38%
Governments0.04%
The Boeing Co.0.02%
Individuals0.01%
Unknown18.40%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 52.42%
United Kingdom 19.77%
Norway 1.63%
Singapore 1.33%
Netherlands 0.87%
Switzerland 0.83%
France 0.67%
Germany 0.57%
Canada 0.56%
Japan 0.36%
Sweden 0.36%
Australia 0.32%
Denmark 0.30%
Luxembourg 0.28%
South Korea 0.18%
Ireland 0.18%
Kuwait 0.13%
Hong Kong 0.13%
Spain 0.10%
Qatar 0.09%
Italy 0.08%
New Zealand 0.08%
Finland 0.07%
South Africa 0.05%
Belgium 0.04%
Austria 0.03%
Botswana 0.02%
Liechtenstein 0.02%
Malaysia 0.02%
Vatican City 0.02%
Individuals 0.01%
Portugal 0.01%
Kazakhstan 0.01%
Peru 0.01%
Cayman Islands 0.01%
Thailand 0.01%

Based on 1000 largest holdings

Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Employees
25,408
More about the company
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW